Noringriis IM, Donia M, Madsen K, Schmidt H, et al. Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab. Br J Cancer 2025 May 26. doi: 10.1038/s41416-025-03048.
PMID: 40419744